📋 Tender Overview
The DAK-Gesundheit intends to conclude non-exclusive discount agreements for pharmaceuticals under § 130a Abs. 8 SGB V, specifically for the active ingredient Capsaicin, ATC N01BX04. The process involves formal procurement procedures for the specified pharmaceuticals, allowing all interested pharmaceutical companies to enter into discount agreements. The contracts will commence on 01.09.2026 and end on 31.08.2028, with an option for a 12-month extension. Interested parties must submit required documents by the specified deadlines to participate. Capsaicin, ATC N01BX04
